TARA — Protara Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Dollar General, Hewlett Packard Enterprise, Ford
Protara Therapeutics gains on mid-stage data on bladder cancer therapy
Brief: Protara Announces Positive Results From The Ongoing Phase 2 Advanced-2 Trial Of TARA-002 In Patients With NMIBC
Protara Therapeutics Inc reports results for the quarter - Earnings Summary
Brief: Protara Therapeutics Q3 EPS USD -0.5
Protara Therapeutics Inc expected to post a loss of 52 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-3M, VF Corp, SiriusXM
U.S. STOCKS ON THE MOVE-Howmet Aerospace, Alaska Air, Arcus Biosciences
Protara climbs on FDA's 'fast track' tag for nutritional therapy
Brief: Protara Therapeutics Granted FDA Fast Track Designation For Intravenous Choline Chloride For Patients Receiving Parenteral Support
Protara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Protara Therapeutics Q2 EPS USD -0.45
Protara Therapeutics Inc expected to post a loss of 80 cents a share - Earnings Preview
Protara Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: Protara Therapeutics Q1 EPS USD -0.97
Protara Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Protara Therapeutics Announces Alignment With FDA On Registrational Path Forward For IV Choline Chloride
Brief: Protara Therapeutics Announces Positive Three-Month Data From TARA-002 Clinical Program In NMIBC
Brief: Protara Therapeutics Q4 EPS USD -0.9